A1 Refereed original research article in a scientific journal

99mTc-labeled rHuEpo for imaging of the erythropoietin receptor in tumors




AuthorsZhuang XQ, Zhao D, Yang PF, Jia YQ, Liang R, Zhao Q, Han CL, Kinsella JM, Sheng RL, Li J

PublisherWILEY

Publication year2018

JournalJournal of Labelled Compounds and Radiopharmaceuticals

Journal name in sourceJOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS

Journal acronymJ LABELLED COMPD RAD

Volume61

Issue2

First page 77

Last page83

Number of pages7

ISSN0362-4803

eISSN1099-1344

DOIhttps://doi.org/10.1002/jlcr.3586


Abstract
To analyze erythropoietin receptor (EpoR) status in tumors, recombinant human erythropoietin (rHuEpo) was labeled with Tc-99m by Tc-99m-centered 1-pot synthesis, resulting in high radiochemical purity, stability, and biological activity. Both in vitro cell culture experiments and biodistribution studies of normal rats demonstrated successful EpoR targeting. The biodistribution of labeled rHuEpo in a NCI-H1975 xenograft model showed tumor accumulation (tumor-to-muscle ratio, 4.27 +/- 1.77), confirming the expression of active EpoR in tumors. Thus, as a novel single positron emission computerized tomography tracer for the imaging of EpoR expression in vivo, Tc-99m-rHuEpo is effective for exploring the role of EpoR in cancer growth, metastasis and angiogenesis.



Last updated on 2024-26-11 at 21:03